ProShares Ultra Nasdaq Biotechnology (BIB:NASDAQ) closed at $110.32 on October 23, 2026, down 2.15% on the day. The stock trades 12.7% below its 52-week high of $126.40 and 64.9% above its 52-week low of $66.89. Over the past year, it gained 64.7%. ProShares Ultra Nasdaq Biotechnology is part of the Miscellaneous sector.
In 252 trading sessions since October 23, 2025, BIB closed higher on 139 days (55%). Its best day was August 19, 2026 (+12.72%) and its worst was March 27, 2026 (-5.87%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 1 time.
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Find more stocks like BIB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.